本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

NRX Pharmaceuticals Inc.

2.08
+0.02991.46%
成交量:13.51万
成交额:28.17万
市值:3,518.29万
市盈率:-0.88
高:2.14
开:2.10
低:2.05
收:2.05
数据加载中...
2021/10/13

重要事件披露

8-K - Current report
2021/09/13

SEC问询函

CORRESP [Cover] - Correspondence
2021/09/10

重要事件披露

8-K - Current report
2021/09/03

招股说明书

S-1 - General form for registration of securities under the Securities Act of 1933
2021/08/24

重要事件披露

8-K - Current report
2021/08/20

重要事件披露

8-K - Current report
2021/08/19

重要事件披露

8-K - Current report
2021/08/16

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/07/29

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2021/07/07

SEC问询函

CORRESP [Cover] - Correspondence
2021/07/06

[修订]招股说明书

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2021/06/25

招股说明书

S-1 - General form for registration of securities under the Securities Act of 1933
2021/06/04

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2021/06/03

超过5%披露

SC 13D - General statement of acquisition of beneficial ownership
2021/05/28

重要事件披露

8-K - Current report
2021/05/28

重要事件披露

8-K - Current report
2021/05/26

重要事件披露

8-K - Current report
2021/05/26

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2021/05/24

重要事件披露

8-K - Current report
2021/05/24

交易所摘牌声明

25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities